Гормональные особенности циклов ЭКО, стимулированных человеческим менопаузальным гонадотропином и рекомбинатным ФСГ в протоколах с антагонистом гонадотропин-рили-зинг гормона
- Авторы: Виноградова Л.В.1, Мишиева Н.Г.1, Абубакиров А.Н.1, Левков Л.А.1, Мартынова М.В.1
-
Учреждения:
- ФГБУ НЦАГиП им. академика В.И. Кулакова Минздрава России
- Выпуск: № 11 (2014)
- Страницы: 88-95
- Раздел: Статьи
- URL: https://journals.eco-vector.com/0300-9092/article/view/247305
- ID: 247305
Цитировать
Полный текст
![Открытый доступ](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_open.png)
![Доступ закрыт](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_unlock.png)
![Доступ закрыт](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_lock.png)
Аннотация
Полный текст
![Доступ закрыт](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_lock.png)
Об авторах
Любовь Валерьевна Виноградова
ФГБУ НЦАГиП им. академика В.И. Кулакова Минздрава России
Email: Kalugina-LV@mail.ru
аспирант
Нонна Годовна Мишиева
ФГБУ НЦАГиП им. академика В.И. Кулакова Минздрава России
Email: nondoc555@mail.ru
д.м.н., в.н.с. 1-го гинекологического отделения
Айдар Назимовича Абубакиров
ФГБУ НЦАГиП им. академика В.И. Кулакова Минздрава России
Email: nondoc555@yahoo.com
к.м.н., руководитель 1-го гинекологического отделения
Лев Алексеевич Левков
ФГБУ НЦАГиП им. академика В.И. Кулакова Минздрава России
Email: lev.levkov@gmail.com
к.м.н., советник директора
Мария Валерьевна Мартынова
ФГБУ НЦАГиП им. академика В.И. Кулакова Минздрава России
Email: Martinova_m@bk.ru
аспирант
Список литературы
- Fleming R., Lloyd F., Herbert M., Fenwick J., Griffiths T., Murdoch A. Effects of profound suppression of luteinizing hormone during ovarian stimulation on follicular activity, oocytes and embryo function in cycles stimulated with purified follicle stimulating hormone. Hum. Reprod. 1998; 13: 1788-92.
- Strehler E., Abt M., El-Danasouri I., De Santo M., Sterzik K. Impact of recombinant follicle-stimulating hormone and human menopausal gonadotrophins on in vitro fertilization outcome. Fertil. Steril. 2001; 75: 332-6.
- Кулаков В.И., ред. Бесплодный брак (современные подходы к диагностике и лечению): руководство для врачей. М.: ГЭОТАР-Медиа; 2005: 10-21. [Kulakov V.I., eds. Sterile marriage (current approaches to diagnosis and treatment): a guide for physicians. M.: GEOTAR Media; 2005: 10-21. In Russ.]
- Kolibianakis E.M., Schultze-Mosgau A., Schroer A., van Steirteghem A., Devroey P., Diedrich K., Griesinger G. A lower ongoing pregnancy rate can be expected when GnRH agonist is used for triggering final oocyte maturation instead of HCG in patients undergoing IVF with GnRH antagonists. Hum. Reprod. 2005; 20: 2887-92.
- Andersen A.N., Devroey P., Arce J.C. Clinical outcome following stimulation with highly purified hMG or recombinant FSH in patients undergoing IVF: a randomized assessor-blind controlled trial. Hum. Reprod. 2006; 21(12): 3217-27.
- Devroey P., Pellicer A., Nyboe Andersen A., Arce J.C.; Menopur in GnRH Antagonist Cycles with Single Embryo Transfer Trial Group. A randomized assessor-blind trial comparing highly purified hMG and recombinant FSH in a GnRH antagonist cycle with compulsory single blastocyst transfer. Fertil. Steril. 2012; 97(3): 561-71. doi: 10.1016/j. fertnstert.2011.12.016.
- Platteau P., Nyboe Andersen A., Loft A., Smitz J., Danglas P., Devroey P. Highly purified HMG versus recombinant FSH for ovarian stimulation in IVF cycles. Reprod. Biomed. Online. 2008; 17(2): 190-8. www.rbmonline. com/Article/3332 on web 19 June 2008.
- Engel J.B., Riethmuller-Winzen H., Diedrich K. Extrapituitary effects of GnRH antagonists in assisted reproduction: a review. Reprod. Biomed. Online. 2005; 10: 230-4.
- Felberbaum R.E., Diedrich K. Gonadotropin-releasing hormone antagonists: will they replace the agonists? Reprod. Biomed. Online. 2003; 6(1): 43-53.
- Hofmann G.E., Bentzien F., Bergh P.A., Garrisi G.J., Williams M.C., Guzman I., Navot D. Premature luteinization in controlled ovarian hyperstimulation has no adverse effect on oocyte and embryo quality. Fertil. Steril. 1993; 60(4): 675-9.
- Fanchin R., de Ziegler D., Taieb J., Hazout A., Frydman R. Premature elevation of plasma progesterone alters pregnancy rates of in vitro fertilization and embryo transfer. Fertil. Steril. 1993; 59(5): 1090-4.
- Bosch E., Valencia I., Escudero E., Crespo J., Simon C., Remohf J., Pellicer A. Premature luteinization during gonadotropin-releasing hormone antagonist cycles and its relationship with in vitro fertilization outcome. Fertil. Steril. 2003; 80(6): 1444-9.
- Elnashar A.M. Progesterone rise on the day of HCG administration (premature luteinization) in IVF: an overdue update. J. Assist. Reprod. Genet. 2010; 27(4: 149-55.
- Papanikolaou E.G., Kolibianakis E.M,, Pozzobon C., Tank P., Tournaye H., Bourgain C. et al. Progesterone rise on the day of human chorionic gonadotropin administration impairs pregnancy outcome in day 3 single-embryo transfer, while has no effect on day 5 single blastocyst transfer. Fertil. Steril. 2009; 91(3): 949-52.
- Venetis C.A., Kolibianakis E.M., Papanikolaou E., Bontis J., Devroey P., Tarlatzis B.C. Is progesterone elevation on the day of human chorionic gonadotrophin administration associated with the probability of pregnancy in in vitro fertilization? A systematic review and meta-analysis. Hum. Reprod. Update. 2007; 13(4): 343-55.
- Fleming R., Chung C.C., Yates R.W.S., Coutts J.R. Purified urinary follicle stimulating hormone induces different hormone profiles compared with menotrophin, dependent upon the route of administration and endogenous luteinizing hormone activity. Hum. Reprod. 1996; 11(9): 1854-8.
- Westergaard L.G., Laursen S.B., Andersen C.Y. Increased risk of early pregnancy loss by profound suppression of luteinizing hormone during ovarian stimulation in normogonadotrophic women undergoing assisted reproduction. Hum. Reprod. 2000; 15: 1003-8.
- Agrawal R., Conway G.S., Engmann L. Implications of using follicle-stimulating hormone preparations depleted of luteinizing hormone to achieve follicular growth in in vitro fertilization. Gynecol. Endocrinol. 1998; 12: 9-15.
- Weston A.M., Zelinski-Wooten M.B., Hutchison J.S., Stouffer R.L., Wolf D.P. Developmental potential of embryos produced by in-vitro fertilization from gonadotrophin-releasing hormone antagonist-treated macaques stimulated with recombinant human follicle stimulating hormone alone or in combination with luteinizing. Hum. Reprod. 1996;11(3): 608-13.
- Filicori M., Cognigni G.E., Taraborrelli S., Spettoli D., Ciampaglia W., Tabarelli de Fatis C. et al. Luteinizing hormone activity in menotrophins optimizes folliculogenesis and treatment in controlled ovarian stimulation. J. Clin. Endocrinol. Metab. 2001; 86: 337-43.
- Payne A.H., Hales D.B. Overview of steroidogenic enzymes in the pathway from cholesterol to active steroid hormones. Endocr. Rev. 2004; 25(6): 947-70.
- Young E.L., Hillier S.G., Turner M., Baird D.T., Ng S.C., Bongso A., Ratnam S.S. Differential regulation of cholesterol side-chain cleavage (P450scc) and aromatase (P450arom) enzyme mRNA expression by gonadotrophins and cyclic AMP in human granulosa cells. J. Mol. Endocrinol. 1994; 12(2): 239-49.
- Kolibionakis E.M., Zikopoulos K., Schiettecatte J., Smitz J., Tournaye H., Camus M. et al. Profound LH suppression after GnRH antagonist administration is associated with a signifycantle higher ongoing pregnancy rate in IVF. Hum. Reprod. 2004; 19(11): 2490-6.
- Bosch E., Labarta E., Crespo J., Simon C., Remohi J., Jenkins J., Pellicer A. Circulating progesterone levels and ongoing pregnancy rates in controlled ovarian stimulation cycles for in vitro fertilization: analysis of over 4000 cycles. Hum. Reprod. 2010; 25: 2092-100.
- Van Vaerenbergh I., Fatemi H.M., Blockeel C., Van Lommel L., In’t Veld P., Schuit F. et al. Progesterone rise on HCG day in GnRH antagonist /rFSH stimulated cycles affects endometrial gene expression. Reprod. Biomed. Online. 2011; 22(3): 263-71.
- Melo M.A., Meseguer M., Garrido N., Bosch E., Pellicer A., Remohi J. The significance of premature luteinization in an oocyte-donation programme. Hum. Reprod. 2006; 21(6): 1503-7.
- Fanchin R., Righini C., Olivennes F., Ferreira A.L., de Ziegler D., Frydman R. Consequences of premature progesterone elevation on the outcome of in vitro fertilization: insights into a controversy. Fertil. Steril. 1997; 68(5): 799-805.
- Hugues J.N. Impact of ‘LH activity’ supplementation on serum progesterone levels during controlled ovarian stimulation: a systematic review. Hum. Reprod. 2012; 27(1): 232-43.
Дополнительные файлы
![](/img/style/loading.gif)